Reply to D.L. Raunig
暂无分享,去创建一个
B. Freidlin | E. Korn | L. Dodd | L. Rubinstein | J. Dancey | M. Mooney | C. Jaffe
[1] D. Raunig. Are onsite image evaluations the solution or are we trading one problem for another? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] B. Freidlin,et al. Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.